Jane Chung serves as Executive at SUTRO BIOPHARMA, INC., where they oversee executive responsibilities. Since joining the company, Jane Chung has executed 17 insider transactions totaling $10.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 12, 2025 involved exercising options for 2,500 shares valued at $0.
Jane Chung currently holds 14,785 shares of SUTRO BIOPHARMA, INC. (STRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jane Chung has been a net buyer of STRO stock. They have purchased $10.0K and sold $0 worth of shares.
Jane Chung's most recent insider trade was on Dec 12, 2025, when they sold 2,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $8.02 |
| Discretionary |
| Oct 15, 2025 | STRO | $10.0K | Purchase | 12,500 | $0.80 | Discretionary |
| Aug 9, 2025 | STRO | $5.4K | Payment | 6,708 | $0.80 | Discretionary |
| Aug 9, 2025 | STRO | $0 | Option Exercise | 18,750 | $N/A | Discretionary |
| Aug 9, 2024 | STRO | $0 | Option Exercise | 18,750 | $N/A | Discretionary |
| Aug 9, 2024 | STRO | $20.9K | Payment | 6,689 | $3.12 | Discretionary |
| Mar 4, 2024 | STRO | $10.6K | Payment | 2,209 | $4.79 | Discretionary |
| Mar 4, 2024 | STRO | $0 | Option Exercise | 7,875 | $N/A | Discretionary |
| Mar 1, 2024 | STRO | $10.1K | Payment | 2,038 | $4.95 | Discretionary |
| Mar 1, 2024 | STRO | $0 | Option Exercise | 6,875 | $N/A | Discretionary |
| Aug 9, 2023 | STRO | $27.4K | Payment | 6,483 | $4.22 | Discretionary |
| Aug 9, 2023 | STRO | $0 | Option Exercise | 18,750 | $N/A | Discretionary |
| Mar 3, 2023 | STRO | $18.6K | Payment | 3,211 | $5.79 | Discretionary |
| Mar 3, 2023 | STRO | $0 | Option Exercise | 7,875 | $N/A | Discretionary |
| Aug 9, 2022 | STRO | $0 | Option Exercise | 18,750 | $N/A | Discretionary |
| Aug 9, 2022 | STRO | $42.8K | Payment | 6,483 | $6.60 | Discretionary |